Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Thursday, October 19, 2017
Wednesday, October 18, 2017
Texas Board of Pharmacy Adopted and Proposed Rules: Board to Consider Proposed Rules at November 7, 2017 Meeting
|
Anthem expects $4 billion in savings with pharmacy deal
KFGO-8 hours ago
NEW YORK (Reuters) - U.S. health insurer Anthem Inc expects $4 billion in savings starting in 2021 from its plan to end its current pharmacy contract and start ...
Updated FDA Manual Offers Inside Look at Inspection Protocols | RAPS
2 hours ago - Are misbranded, unapproved, fraudulent, or compounded drugs containing ingredients that have been withdrawn or removed from the market for safety or effectiveness reasons, or compounded drugs that contain bulk active ingredients that are not components of FDA-approved drugs."
Subscribe to:
Posts (Atom)